Clinical Trials


Lymphoma Non-Transplant Trial Finder

Click on the headings below to view relevant trials for the condition listed.

Indolent Lymphoma: Newly Diagnosed/Untreated (1 trial + 1 pending)

Indolent Lymphoma: Relapsed/Refractory (5 trials)

Aggressive Lymphoma: Newly Diagnosed/Untreated (3 trials + 1 pending)

Aggressive Lymphoma: Relapsed/Refractory (5 trials, 1 pending)

Hodgkin Lymphoma: Newly Diagnosed/Untreated (0 trials)

  • Trials pending. None currently open.

Hodgkin Lymphoma: Newly Diagnosed/Advanced Stage (1 trial)

Hodgkin Lymphoma: Relapsed/Refractory (3 trials, 1 pending)

Mantle-Cell Lymphoma: Newly Diagnosed/Untreated (1 trial pending)

Mantle-Cell Lymphoma: Relapsed/Refractory (1 trial)

T-Cell Lymphoma (4 trials)

Chronic Lymphocytic Leukemia: Untreated or Consolidation (1 trial)

  • Vorinostat + Chemotherapy for CLL or SLL (PSOC-2401)
    A Phase I/II Study of Fludarabine (F), Cyclophosphamide ©), Rituximab ®), and Vorinostat (V) Followed by RV Maintenance Therapy in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small LymphoCtic Lymphoma (SLL)

Chronic Lymphocytic Leukemia: Relapsed/Refractory (6 trials)

Clinical Trial Finder beta 2 updated 2/5/2014.